Login
Résultat de la recherche (1-20 par 83)Download
|
Symbol
|
RMA0EV | OSLRCH | ABICTQ | RMBQ5V | KZEHDU | PELRCH | ABRBTQ | KZJVDU | CJWBKB | PHTRCH | RMBAIV | ACBBSQ | Z0AK9Z | Z0AKAZ | PLSRCH | ABYHTQ | ACGJTQ | BGLBIL | PUIRCH | ACIPTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | NextEra Energy Inc. / Novo Nordisk AS (B) / Reckitt Benckiser Group Plc. | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Sanofi S.A. | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | Moderna Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Bayer AG / Eli Lilly & Co. / Novo Nordisk AS (B) |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
15.06.2026 | 19.08.2026 | 05.05.2026 | 17.11.2026 | 20.11.2026 | 08.05.2026 | 10.06.2026 | 30.12.2026 | 05.06.2026 | 09.06.2026 | 30.12.2026 | 30.06.2026 | 13.07.2026 | 13.07.2026 | 13.07.2026 | 21.07.2026 | 03.09.2026 | 28.08.2026 | 17.09.2026 | 11.06.2026 |
| Demande | 25,800 | 31,230 | 35,700 | 39,500 | 38,450 | 35,200 | 34,240 | 35,600 | 36,380 | 35,100 | 46,900 | 43,830 | - | - | 41,960 | 47,390 | 44,260 | 50,75 | 46,920 | 45,240 |
| Offre | - | - | - | - | 39,450 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
S'il vous plait attendre
Le push de données de prix a été désactivé en raison d'un timeout. S'il vous plaît cliquez sur "Actualiser la page" pour continuer.
Votre mémo (0)